POLB vs. ORPH, OBI, REDX, ETX, SBTX, COS, C4XD, DDDD, FUM, and TRX
Should you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include Open Orphan (ORPH), Ondine Biomedical (OBI), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), and Tissue Regenix Group (TRX). These companies are all part of the "biotechnology" industry.
Poolbeg Pharma vs. Its Competitors
Open Orphan (LON:ORPH) and Poolbeg Pharma (LON:POLB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.
In the previous week, Open Orphan's average media sentiment score of 0.00 equaled Poolbeg Pharma'saverage media sentiment score.
Open Orphan's return on equity of 0.00% beat Poolbeg Pharma's return on equity.
Open Orphan and Poolbeg Pharma both received 0 outperform votes by MarketBeat users.
Open Orphan has higher revenue and earnings than Poolbeg Pharma.
1.2% of Poolbeg Pharma shares are owned by institutional investors. 24.7% of Poolbeg Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Open Orphan and Poolbeg Pharma tied by winning 3 of the 6 factors compared between the two stocks.
Get Poolbeg Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Poolbeg Pharma Competitors List
Related Companies and Tools
This page (LON:POLB) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy POLB Stock Free POLB Stock Alerts